APA (7th ed.) Citation

Chon, Y. E., Kim, D. Y., Chon, H. J., & Kim, D. Y. Correspondence to editorial on “Sorafenib vs. Lenvatinib in advanced hepatocellular carcinoma after atezolizumab/bevacizumab failure: A real-world study”. Korean Association for the Study of the Liver.

Chicago Style (17th ed.) Citation

Chon, Young Eun, Dong Yun Kim, Hong Jae Chon, and Do Young Kim. Correspondence to Editorial on “Sorafenib Vs. Lenvatinib in Advanced Hepatocellular Carcinoma After Atezolizumab/bevacizumab Failure: A Real-world Study”. Korean Association for the Study of the Liver.

MLA (9th ed.) Citation

Chon, Young Eun, et al. Correspondence to Editorial on “Sorafenib Vs. Lenvatinib in Advanced Hepatocellular Carcinoma After Atezolizumab/bevacizumab Failure: A Real-world Study”. Korean Association for the Study of the Liver.